AbbVie Inc. is a healthcare company and its current stock price stands at 151.31 USD with changesPercentage of 1.1904%. The company has seen a significant increase in revenue over the years and this has been largely consistent across all quarters.
The financials for AbbVie Inc reveal that the most recent quarter ending 9th February 2023 saw an estimated revenue of 15.31 bln USD which was lower than the actual reported revenue for the quarter ending 28 October 2022, which was 14.81 bln USD, but still significantly higher than the 135.38 bln USD recorded in April 2022, and 14.89 bln USD reported in February 2022 quarter ending 31 December 2021.
Looking at the year-on-year data, it appears that AbbVie Inc’s revenues have been steadily increasing since 2021 with a peak being achieved in October 2022 at 14.81 bln USD before declining slightly over the following two quarters to 15.31 bln USD estimated for 9th February 2023 and 135.38 bln USD recorded in April 2022 respectively.
Overall, it seems that AbbVie Inc’s financials have been steadily improving over time with its revenue remaining stable or increasing year on year since 2021 thus indicating a healthy financial situation for the company going forward into 2024 and beyond.